Table 2. Fasting blood sugar (FBS), plasma level of insulin and HOMA-IR test at the end of treatment protocol.

Groups	Non-Diabetic	Diabetic	Diabetic+Vilda
FBS (mmol/l)	5.28±0.18	28.60±0.50***	20.06±0.25***
Insulin (µu/ml)	4.64± 0.27	7.33±0.14***	9.52±0.20***
HOMA1-IR	1.08±0.05	9.31±0.18***	8.23±0.50***

The data were expressed as mean ± SEM. n=10 for each group. Vilda: vildagliptin; HOMA1-IR: homeostasis model assessment-estimated insulin resistance.^***p<0.001 as compared with non-diabetic group and ⁺⁺p<0.01 and ⁺⁺⁺p<0.001 as compared with diabetic group.